Cite Filings / MLYS / 0001964306-26-000103

Feed Companies Filings Check

Sign in

144

Sale of Securities

Mineralys Therapeutics, Inc. Filed 2026-02-17 Acc 0001964306-26-000103

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2026-03-09 144 Sale of Securities
2026-02-20 4 Chief Executive Officer acquired 140,900 shares (grant or award)
2026-02-20 4 Chief Medical Officer acquired 38,400 shares (grant or award)
2026-02-20 4 Director acquired 6,200 shares (grant or award)
2026-02-17 144 Sale of Securities
2026-02-17 4 Chief Medical Officer sold 417 shares at $27.59 ($11,505)
2026-02-13 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…